World Lupus Federation Global Survey of People with Lupus Finds Half of Respondents Experienced a Decrease in Access to Healthcare During Pandemic
PR89037
World Lupus Federation Global Survey of People with Lupus Finds Half of Respondents Experienced a Decrease in Access to Healthcare During COVID-19 Pandemic
WASHINGTON, April 22, 2021 /PRNewswire=KYODO JBN/ --
-- Over one third of survey respondents living with lupus were unable
to access the COVID-19 vaccine earlier than the general population
In a new global survey, more than 6,100 people with lupus from over 85
countries shared their recent experiences of the COVID-19 pandemic and their
views of the COVID-19 vaccines. Half (50%) of the survey participants reported
decreased access to at least one aspect of lupus healthcare during the last
three months, including decreased access to their lupus doctor/rheumatologist
(36%), medical tests (29%), infusions for lupus treatment (24%) and lupus
medications (17%).
Logo - https://mma.prnewswire.com/media/1488983/World_Lupus_Federation_Logo.jpg
The international survey conducted by the World Lupus Federation further
outlines how those living with lupus have been uniquely impacted during the
COVID-19 pandemic. The survey also found that 10% of those surveyed have been
infected with COVID-19, well above the global average of confirmed cases.
Further, the respondents who reported reduced access to lupus healthcare were
also more likely to have reported a lupus-related health complication,
including lupus flares and lupus-related hospitalizations.
"People with lupus around the world continue to experience significant
obstacles and as a result, serious negative health outcomes due to the COVID-19
pandemic. There are many causes for the challenges with access to care and
treatments, including apprehension of going to doctor's appointments due to
fear of risk of COVID-19 infection," shared Paul Howard, CEO of LUPUS UK.
"Access to specialised care and the medications they depend on is incredibly
important for those living with lupus. Without it, people with lupus can face
adverse health outcomes and even require hospitalisation."
In addition to significant issues with access to care, the survey found unique
challenges for people with lupus regarding COVID-19 vaccinations. Over one
third of respondents (35%) were unable to access the vaccine earlier than the
general population in their local area, even though lupus can put people at
higher risk of infections or a weakened immune system due to the effects of
immune-suppressing lupus treatments.
Three quarters of respondents (75%) reported concerns about the COVID-19
vaccine, including the possible side effects of the vaccine (68%) and the
interaction of the vaccine with lupus and/or lupus medications (61%).
"It is highly recommended that people with lupus receive the COVID-19 vaccine,
but there are considerations to take into account," shared Karen H.
Costenbader, MD, MPH, Director of the Lupus Program at Brigham and Women's
Hospital in Massachusetts, United States. "People living with lupus should
discuss their vaccination plan with their doctor to find out how their current
treatment regimen may affect vaccine responses and to decide on the best
timing. It's another extra step that people with lupus must take during this
difficult time as we all strive to 'get back to normal' as much as possible."
Click here (
) to view a topline summary and detailed survey results (
), and join us on May 10 as we take steps to make lupus visible across the
globe for World Lupus Day (
).
About the World Lupus Federation
The World Lupus Federation (
) (WLF) is a coalition of lupus (
) patient organizations, united to improve the quality of life for all people
affected by lupus. Through coordinated efforts among its affiliates, the
Federation works to expand global initiatives that create greater awareness and
understanding of lupus, provide education and services to people living with
the disease and advocate on their behalf.
MEDIA CONTACT
Mike Donnelly
Lupus Foundation of America
donnelly@lupus.org
(202) 349-1162
Source - World Lupus Federation
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。